asa glp 1 agonist guidelines A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia GLP-1 RA guidance roundup -
Description
In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide

Joshua Silva, MD explains the science, the risks, and when to stop medication before pregnancy.

The surprising science and sobering risks revealed.

Nearly 90% of Americans are now aware of GLP-1 drugs and their uses.

19, 2024 (HealthDay News) -- The U.S

How GLP-1 and GIP pathways work, why dual-action tirzepatide (Mounjaro) differs from GLP-1-only medicines, and what trial averages mean for UK patients.